192 related articles for article (PubMed ID: 23907469)
1. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma.
Huang YK; Peng BY; Wu CY; Su CT; Wang HC; Lai HC
Clin Oral Investig; 2014 Apr; 18(3):801-8. PubMed ID: 23907469
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma.
Sun R; Juan YC; Su YF; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X
J Oral Pathol Med; 2020 Sep; 49(8):751-760. PubMed ID: 32428271
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer.
Cheng SJ; Chang CF; Lee JJ; Chen HM; Wang HJ; Liou YL; Yen C; Chiang CP
Oral Oncol; 2016 Nov; 62():34-43. PubMed ID: 27865370
[TBL] [Abstract][Full Text] [Related]
5. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
Chang CC; Huang RL; Wang HC; Liao YP; Yu MH; Lai HC
Int J Gynecol Cancer; 2014 Feb; 24(2):201-9. PubMed ID: 24407576
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
Cheng SJ; Chang CF; Ko HH; Lee JJ; Chen HM; Wang HJ; Lin HS; Chiang CP
Head Neck; 2018 Feb; 40(2):355-368. PubMed ID: 28960639
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DNA methylation in matched oral swab and tissue specimens from Chinese patients with oral squamous cell carcinoma.
Sun R; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X
Int J Oral Maxillofac Surg; 2021 Jun; 50(6):725-732. PubMed ID: 33023801
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer.
Cheng SJ; Chang CF; Ko HH; Liu YC; Peng HH; Wang HJ; Lin HS; Chiang CP
Oral Oncol; 2017 Dec; 75():169-177. PubMed ID: 29224816
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.
Huang J; Wang G; Tang J; Zhuang W; Wang LP; Liou YL; Liu YZ; Zhou HH; Zhu YS
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28241446
[TBL] [Abstract][Full Text] [Related]
10. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
[TBL] [Abstract][Full Text] [Related]
11. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
[TBL] [Abstract][Full Text] [Related]
12. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
13. PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians.
Chen Y; Cui Z; Xiao Z; Hu M; Jiang C; Lin Y; Chen Y
Ann Transl Med; 2016 Oct; 4(19):365. PubMed ID: 27826568
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylated status and gene expression of
Huang J; Tan ZR; Yu J; Li H; Lv QL; Shao YY; Zhou HH
Onco Targets Ther; 2017; 10():4739-4751. PubMed ID: 29033587
[TBL] [Abstract][Full Text] [Related]
15.
Zhao Z; Zhang X; Zhao X; Cai J; Wu NY; Wang J
Biomed Res Int; 2020; 2020():3981529. PubMed ID: 33376722
[TBL] [Abstract][Full Text] [Related]
16. ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions.
Juan YC; Su YF; Bai CH; Fan YC; Kuo TT; Ko HH; Peng HH; Chiang CP; Fwu CW; Cheng SJ
Oral Dis; 2023 Mar; 29(2):505-514. PubMed ID: 34145953
[TBL] [Abstract][Full Text] [Related]
17. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
18. Is OLP potentially malignant? A clue from ZNF582 methylation.
Chiu YW; Su YF; Yang CC; Liu CJ; Chen YJ; Cheng HC; Wu CH; Chen PY; Lee YH; Chen YL; Chen YT; Peng CY; Lu MY; Yu CH; Kao SY; Fwu CW; Huang YF
Oral Dis; 2023 Apr; 29(3):1282-1290. PubMed ID: 34967949
[TBL] [Abstract][Full Text] [Related]
19. PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis.
Kong LY; Du W; Wang L; Yang Z; Zhang HS
Clin Lab; 2015; 61(10):1471-9. PubMed ID: 26642709
[TBL] [Abstract][Full Text] [Related]
20. Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer.
Su PH; Lai HC; Huang RL; Chen LY; Wang YC; Wu TI; Chan MWY; Liao CC; Chen CW; Lin WY; Chang CC
Sci Rep; 2019 Jun; 9(1):9195. PubMed ID: 31235851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
